logo
episode-header-image
Nov 2020
39m 10s

A Vaccine Boost

The Motley Fool
About this episode
Pfizer announces encouraging results from its COVID-19 vaccine. Disney gives investors 73 million reasons for optimism. Beyond Meat reports a surprising loss. Lyft reports a surprising increase in revenue. And DoorDash prepares for an IPO. Motley Fool analysts Ron Gross and Jason Moser discuss those stories and weigh in on the latest from Cisco Systems, Draf ... Show More
Up next
Yesterday
Reckless Earnings Predictions: ZM, BBY, DE
We enter Thanksgiving week with a plate full of reckless predictions featuring Zoom (reports today), Best Buy (reports tomorrow morning), and Deere & Co. (reports tomorrow morning). Rick Munarriz, David Meier, and Tim Beyers: - Forecast a “miss, beat, or beat and raise” for Z ... Show More
24 m
Nov 23
Interview with Mark Matson: Experiencing the American Dream
What’s the first step in building wealth? How do we know if we’re on track financially? What does abundance look like? Motley Fool contributor Rich Lumelleau talks with Matson Money Founder and CEO Mark Matson, author of Experiencing The American Dream: How to Invest Your Time, E ... Show More
19m 1s
Nov 22
Advocate for a Better 401(k) and Tax-Smart Charitable Giving
For many Americans, contributing to an employer-sponsored plan is the primary way they’re saving for retirement. Unfortunately, not all of these plans are excellent, and you’re stuck with the investment choices and features chosen by your employer.Or are you? Longtime Motley Fool ... Show More
22m 47s
Recommended Episodes
May 2021
The Reopening Trade: Uber's Revenue Miss, Vaccine Makers Tumble and Peloton After the Sell-off. Earnings Winners and Losers from ViacomCBS and PayPal to Etsy ... Plus "Reunited and It Feels So Good!"
Carl Quintanilla, Jim Cramer and David Faber took a wide-ranging look at the reopening trade: Uber shares under pressure after the company reported a revenue miss, vaccine makers such as Pfizer, BioNTech and Moderna saw their shares take a hit after the Biden Administration annou ... Show More
43m 54s
Dec 2021
After the Rally: Pfizer's COVID Booster vs. Omicron, Apple's Record Run, The EV Battle Intensifies and Stitch Fix Plummets
The morning after the best day for both the S&P 500 and Nasdaq since March, Carl Quintanilla, Jim Cramer and David Faber led off the show with news out of Pfizer and BioNTech: Data shows their COVID-19 vaccine neutralized the omicron variant with three shots. The anchors discusse ... Show More
43m 51s
Aug 2021
Disney Beats the Street and Leads the Stock Market to Record Highs, the FDA's COVID Booster Shot Authorization and Companies’ Approaches to Vaccinations, What Airbnb and DoorDash’s Results Tell Us About the Reopening Trade, and the CEO of the U.S. Chamber of Commerce Talks Infrastructure.
Carl Quintanilla, Morgan Brennan and Mike Santoli led off the show with Disney, whose better-than-expected quarterly results drove the stock higher, leading the Dow and S&P 500 to new record intraday highs. The anchors reacted to what Disney CEO Bob Chapek's told CNBC about Disne ... Show More
43m 46s
Aug 2021
The Chinese Stock Rally and the Cathie Wood Effect, Mandates and the Reopening Trade After Full Approval of Pfizer's COVID Vaccine, Boeing Faces New Scrutiny, Tim Cook's Decade as CEO of Apple, and the CEO of Medtronic Talks Earnings and the Pandemic.
Carl Quintanilla, Jim Cramer and David Faber explored the reasons behind a big rally in shares of China-based companies. One of the catalysts: Cathie Wood's Ark Invest buying almost 165,000 shares of JD.com. The reopening trade very much in focus one day after the FDA fully appro ... Show More
44m 6s
Sep 2021
Understanding Evergrande, Dell’s Post-Spinoff Outlook & Flying Cars
Carl Quintanilla, Jim Cramer and David Faber discuss China’s property market crisis and the Federal Reserve's decision to keep current monetary stimulus in place for just a little bit longer. The Food and Drug Administration has authorized Pfizer and BioNTech’s Covid-19 booster s ... Show More
44m 6s
Aug 2021
Fed Chair Powell and Inflation Watch, Challenges for The Reopening Trade, The FDA and a Third Booster Shot, More Companies Revise Return to Work Plans, Micron As a "Red" Chip, Credit Card Spending Data Airlines Don't Want to Hear, and What to Expect From Disney Earnings
The morning after the Dow and S&P 500 posted record closing highs, Carl Quintanilla, Jim Cramer and David Faber led of the show with new wholesale inflation data: Producer prices for July coming in hotter than expected, rising one percent from the previous month and up 7.8-percen ... Show More
43m 28s
Jul 2021
Stocks Erase Losses from Monday's Sell-off, Dow Components Join the Earnings Parade, Netflix's Subscriber Growth Slowdown, United Sees Profitablilty Ahead, J&J's COVID Vaccine Under Scrutiny, and Chipotle's Results Heat Up the Stock
Jim Cramer and David Faber took an in-depth look at a busy day for the markets with a slew of earnings reports in the mix -- as stocks recouped all of their losses from Monday's sell-off. Dow components Coca-Cola, Johnson & Johnson and Verizon all beating analyst expectations wit ... Show More
43m 12s
Dec 2021
Inflation Surges, Fed "In Trouble," Meme Stock Sadness, Tesla Below $1T Valuation As Musk Sells More Shares, and Pfizer's Antiviral COVID 19-Pill vs. Omicron.
Jim Cramer and David Faber led off the show with market reaction to the latest inflation data: The Producer Price Index shows wholesale prices surged in November, up 9.6% year-over-year. This as the Fed kicks off its final two-day policy meeting of 2021. Cramer explained why he ... Show More
43m 20s
Aug 2021
The FDA Grants Full Approval to Pfizer's COVID Vaccine, Fed Chair Powell and Jackson Hole, Bitcoin Back Above $50K, Wall Street Firms' First Calls on Robinhood, "Gig Stocks" Slump on California Judge's Ruling, and Sir Richard Branson's Virgin Orbit to Go Public Via a SPAC Deal.
Carl Quintanilla, Jim Cramer and David Faber discussed what's ahead for the markets this week in light of the big news of the morning: The FDA officially granting full approval to the Pfizer/BioNTech COVID-19 vaccine. The anchors discussed what this development could mean for the ... Show More
43m 27s
Apr 2024
Fed Decision Kick-Off, Amazon and Apple Results, and Busiest Week of Earnings Season 4/29/24
<p>Investors are awaiting the kickoff to this week's Fed decision. The Milken Institute's Bill Lee gives his expectations. Plus, Amazon and Apple are set to deliver results in what could be two market-moving events. Janus Henderson's Alison Porter explains. And, it's busiest week ... Show More
42m 36s